Genotype and phenotype correlation of patients with osteogenesis imperfecta

Abstract

Osteogenesis imperfecta (OI) is the most common inherited connective tissue disease of the bone, characterized by recurrent fractures and deformities. In patients displaying the OI phenotype, genotype- phenotype correlation is used to screen multiple genes swiftly, identify new variants, and distinguish between differential diagnoses and mild subtypes. This study evaluated variants identified fi ed through next- generation sequencing in 58 patients with clinical characteristics indicative of OI. The cohort included 18 adults, 37 children, and 3 fetuses. Clinical classification fi cation revealed 25 patients as OI type I, three patients as OI type II, 18 as OI type III, and 10 as OI type IV. Fifteen variants in COL1A1 were detected in 19 patients, 9 variants in COL1A2 (n n = 19), 5 variants in LEPRE1/P3H1 (n n = 7), 3 variants in FKBP10 (n n = 4), 3 variants in SERPINH1 (n n = 2), 1 variant in IFITM5 (n n = 1), and 1 variant in PLS3 (n n = 1). In total, 37 variants (18 pathogenic, 14 likely pathogenic, and 5 variants of uncertain significance), fi cance), including 16 novel variants, were identified fi ed in 43 (37 probands, 6 family members) of the 58 patients analyzed. This study highlights the efficacy fi cacy of panel testing in the molecular diagnosis of OI, the significance fi cance of the next-generation sequencing technique, and the importance of genotype-phenotype correlation.